PBSV
Pharma-Bio Serv, Inc.
Price Chart
Latest Quote
$0.57
+0.00 (+0.00%)
Current Price
| Previous Close | $0.57 |
| Open | $0.56 |
| Day High | $0.56 |
| Day Low | $0.56 |
| Volume | 1,700 |
Stock Information
| Shares Outstanding | 22.90M |
| Cash Equivalents | $8.47M |
| Revenue | $9.11M |
| Net Income | $61K |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $13.05M |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.47M |
| Sales | $9.11M |
| Income | $61K |
| Book/sh | $0.45 |
| Cash/sh | $0.37 |
| Employees | 55 |
Financial Ratios
| Quick Ratio | 10.71 |
| Current Ratio | 10.80 |
| EPS Growth TTM | 144.30% |
Returns & Margins
| ROA | -1.95% |
| ROE | 0.55% |
| Gross Margin | 32.35% |
| Operating Margin | 5.35% |
| Profit Margin | 0.68% |
Ownership
| Insider Ownership | 64.94% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 5.18 |
| P/S | 1.43 |
| P/B | 1.28 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $1.55 |
Technical Indicators
| SMA20 | $nan |
| SMA50 | $nan |
| SMA200 | $nan |
| RSI | 50.00 |
| ATR | nan |
| Shares Float | 8.37M |
| Volatility | 0.68 |
| Rel Volume | 2.48 |
Performance History
| Week | +16.33% |
| Month | +5.56% |
| Quarter | +18.75% |
| 6 Months | +18.73% |
| YTD | +8.83% |
| Year | +33.27% |
| 3 Years | -14.44% |
| 5 Years | -18.77% |
| 10 Years | +37.82% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.57 | 0 |
| 2026-06-17 | $0.57 | 0 |
| 2026-06-16 | $0.57 | 0 |
| 2026-06-15 | $0.57 | 3,800 |
| 2026-06-12 | $0.57 | 1,000 |
| 2026-06-11 | $0.49 | 0 |
| 2026-06-10 | $0.49 | 2,000 |
| 2026-06-09 | $0.53 | 0 |
| 2026-06-08 | $0.53 | 0 |
| 2026-06-05 | $0.53 | 0 |
| 2026-06-04 | $0.53 | 1,000 |
| 2026-06-03 | $0.57 | 0 |
| 2026-06-02 | $0.57 | 0 |
| 2026-06-01 | $0.57 | 0 |
| 2026-05-29 | $0.57 | 0 |
| 2026-05-28 | $0.57 | 2,000 |
| 2026-05-27 | $0.58 | 0 |
| 2026-05-26 | $0.58 | 1,000 |
| 2026-05-22 | $0.56 | 0 |
| 2026-05-21 | $0.56 | 1,200 |
| 2026-05-20 | $0.54 | 0 |
| 2026-05-19 | $0.54 | 0 |
About Pharma-Bio Serv, Inc.
Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company offers a broad range of technical compliance consulting services, including regulatory affairs, quality assurance, compliance, technology transfer, validation, engineering, project management, and process support. It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.
đ° Latest News
No news articles available at the moment. Check back later for updates on PBSV.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $6,091,064 | $6,993,241 | $11,910,445 | $14,517,279 |
| Cost Of Revenue | $6,091,064 | $6,993,241 | $11,910,445 | $14,517,279 |
| Total Revenue | $9,001,096 | $9,509,279 | $16,976,856 | $19,398,727 |
| Operating Revenue | $9,001,096 | $9,509,279 | $16,976,856 | $19,398,727 |
| Expenses | ||||
| Total Expenses | $9,638,758 | $10,796,866 | $15,859,445 | $18,223,782 |
| Other Income Expense | $543,402 | $532,139 | $570,076 | $13,418 |
| Other Non Operating Income Expenses | $543,402 | $532,139 | $570,076 | $13,418 |
| Operating Expense | $3,547,694 | $3,803,625 | $3,949,000 | $3,706,503 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-100,463 | $-777,619 | $1,310,180 | $1,006,684 |
| Normalized Income | $-100,463 | $-777,619 | $1,310,180 | $1,006,684 |
| Net Income From Continuing And Discontinued Operation | $-100,463 | $-777,619 | $1,310,180 | $1,006,684 |
| Total Operating Income As Reported | $-637,662 | $-1,287,587 | $1,117,411 | $1,174,945 |
| Net Income Common Stockholders | $-100,463 | $-777,619 | $1,310,180 | $1,006,684 |
| Net Income | $-100,463 | $-777,619 | $1,310,180 | $1,006,684 |
| Net Income Including Noncontrolling Interests | $-100,463 | $-777,619 | $1,310,180 | $1,006,684 |
| Net Income Continuous Operations | $-100,463 | $-777,619 | $1,310,180 | $1,006,684 |
| Pretax Income | $-94,260 | $-755,448 | $1,687,487 | $1,188,363 |
| Operating Income | $-637,662 | $-1,287,587 | $1,117,411 | $1,174,945 |
| Gross Profit | $2,910,032 | $2,516,038 | $5,066,411 | $4,881,448 |
| Per Share | ||||
| Diluted EPS | - | $-0.03 | $0.06 | $0.04 |
| Basic EPS | - | $-0.03 | $0.06 | $0.04 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-408,587 | $-1,106,423 | $1,311,732 | $1,363,336 |
| Reconciled Depreciation | $229,075 | $181,164 | $194,321 | $188,391 |
| EBITDA (Bullshit earnings) | $-408,587 | $-1,106,423 | $1,311,732 | $1,363,336 |
| EBIT | $-637,662 | $-1,287,587 | $1,117,411 | $1,174,945 |
| Diluted NI Availto Com Stockholders | $-100,463 | $-777,619 | $1,310,180 | $1,006,684 |
| Tax Provision | $6,203 | $22,171 | $377,307 | $181,679 |
| Selling General And Administration | $3,547,694 | $3,803,625 | $3,949,000 | $3,706,503 |
| Diluted Average Shares | - | $22,974,124 | $22,997,854 | $23,031,815 |
| Basic Average Shares | - | $22,965,995 | $22,970,892 | $23,002,583 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $11,914,247 | $13,715,327 | $16,126,785 | $16,557,570 |
| Total Assets | $13,653,046 | $16,292,230 | $19,902,061 | $20,650,846 |
| Total Non Current Assets | $266,201 | $593,477 | $500,964 | $707,243 |
| Other Non Current Assets | $120,754 | $225,599 | $111,665 | $130,874 |
| Current Assets | $13,386,845 | $15,698,753 | $19,401,097 | $19,943,603 |
| Other Current Assets | $171,574 | $442,384 | $483,034 | $498,374 |
| Receivables | $2,360,682 | $2,510,909 | $3,940,845 | $4,982,500 |
| Accounts Receivable | $2,360,682 | $2,510,909 | $3,940,845 | $4,982,500 |
| Allowance For Doubtful Accounts Receivable | $-5,300,000 | $-5,300,000 | - | - |
| Gross Accounts Receivable | $7,660,682 | $7,810,909 | - | - |
| Cash Cash Equivalents And Short Term Investments | $10,854,589 | $12,745,460 | $14,977,218 | $14,462,729 |
| Cash And Cash Equivalents | $3,379,212 | $6,767,356 | $10,446,054 | $14,462,729 |
| Prepaid Assets | - | - | - | $498,374 |
| Notes Receivable | - | - | - | - |
| Debt | ||||
| Total Debt | $28,834 | $194,035 | $346,509 | $487,364 |
| Long Term Debt And Capital Lease Obligation | $0 | $28,834 | $194,035 | $346,509 |
| Current Debt And Capital Lease Obligation | $28,834 | $165,201 | $152,474 | $140,855 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,738,799 | $2,576,903 | $3,775,276 | $4,093,276 |
| Total Non Current Liabilities Net Minority Interest | $0 | $689,737 | $1,621,595 | $1,985,557 |
| Tradeand Other Payables Non Current | $0 | $660,903 | $1,427,560 | $1,639,048 |
| Current Liabilities | $1,738,799 | $1,887,166 | $2,153,681 | $2,107,719 |
| Payables And Accrued Expenses | $1,709,965 | $1,721,965 | $2,001,207 | $1,966,864 |
| Payables | $1,709,965 | $1,721,965 | $2,001,207 | $1,966,864 |
| Total Tax Payable | $718,796 | $594,316 | $533,782 | $337,264 |
| Accounts Payable | $991,169 | $1,127,649 | $1,467,425 | $1,629,600 |
| Other Non Current Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $11,914,247 | $13,715,327 | $16,126,785 | $16,557,570 |
| Total Equity Gross Minority Interest | $11,914,247 | $13,715,327 | $16,126,785 | $16,557,570 |
| Stockholders Equity | $11,914,247 | $13,715,327 | $16,126,785 | $16,557,570 |
| Gains Losses Not Affecting Retained Earnings | $278,045 | $262,380 | $210,266 | $238,152 |
| Other Equity Adjustments | $278,045 | $262,380 | $210,266 | $238,152 |
| Retained Earnings | $10,533,589 | $12,353,970 | $14,853,826 | $15,267,470 |
| Other | ||||
| Treasury Shares Number | $613,680 | $561,529 | $549,429 | $514,029 |
| Ordinary Shares Number | $22,905,992 | $22,958,143 | $22,963,451 | $22,943,486 |
| Share Issued | $23,519,672 | $23,519,672 | $23,512,880 | $23,457,515 |
| Tangible Book Value | $11,914,247 | $13,715,327 | $16,126,785 | $16,557,570 |
| Invested Capital | $11,914,247 | $13,715,327 | $16,126,785 | $16,557,570 |
| Working Capital | $11,648,046 | $13,811,587 | $17,247,416 | $17,835,884 |
| Capital Lease Obligations | $28,834 | $194,035 | $346,509 | $487,364 |
| Total Capitalization | $11,914,247 | $13,715,327 | $16,126,785 | $16,557,570 |
| Treasury Stock | $579,286 | $547,843 | $536,580 | $502,236 |
| Additional Paid In Capital | $1,679,547 | $1,644,468 | $1,596,922 | $1,551,838 |
| Capital Stock | $2,352 | $2,352 | $2,351 | $2,346 |
| Common Stock | $2,352 | $2,352 | $2,351 | $2,346 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $0 | $28,834 | $194,035 | $346,509 |
| Current Capital Lease Obligation | $28,834 | $165,201 | $152,474 | $140,855 |
| Net PPE | $145,447 | $367,878 | $389,299 | $576,369 |
| Accumulated Depreciation | $-199,929 | $-658,249 | $-635,009 | $-587,089 |
| Gross PPE | $345,376 | $1,026,127 | $1,024,308 | $1,163,458 |
| Other Properties | $1,491 | $146,524 | $142,670 | $142,670 |
| Machinery Furniture Equipment | $314,497 | $681,006 | $525,188 | $518,103 |
| Buildings And Improvements | $29,388 | $198,597 | $356,450 | $502,685 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $7,475,377 | $5,978,104 | $4,531,164 | $0 |
| Construction In Progress | - | $150,000 | $0 | - |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-221,530 | $-726,444 | $1,883,709 | $573,188 |
| Operating Activities | ||||
| Operating Cash Flow | $-214,886 | $-566,701 | $1,890,960 | $592,457 |
| Cash Flow From Continuing Operating Activities | $-214,886 | $-566,701 | $1,890,960 | $592,457 |
| Operating Gains Losses | - | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-6,644 | $-159,743 | $-7,251 | $-19,269 |
| Investing Cash Flow | $-1,466,391 | $-1,360,868 | $-4,218,338 | $-19,269 |
| Cash Flow From Continuing Investing Activities | $-1,466,391 | $-1,360,868 | $-4,218,338 | $-19,269 |
| Net Other Investing Changes | - | - | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-31,443 | $-11,263 | $-34,344 | $-81,992 |
| Financing Cash Flow | $-1,751,361 | $-1,733,499 | $-1,758,163 | $-3,528,587 |
| Cash Flow From Continuing Financing Activities | $-1,751,361 | $-1,733,499 | $-1,758,163 | $-3,528,587 |
| Cash Dividends Paid | $-1,719,918 | $-1,722,236 | $-1,723,819 | $-3,446,595 |
| Net Common Stock Issuance | $-31,443 | $-11,263 | $-34,344 | $-81,992 |
| Other | ||||
| Interest Paid Supplemental Data | $0 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $528,746 | $661,224 | $422,155 | $211,813 |
| End Cash Position | $3,379,212 | $6,767,356 | $10,446,054 | $14,462,729 |
| Beginning Cash Position | $6,767,356 | $10,446,054 | $14,462,729 | $17,468,345 |
| Effect Of Exchange Rate Changes | $44,494 | $-17,630 | $68,866 | $-50,217 |
| Changes In Cash | $-3,432,638 | $-3,661,068 | $-4,085,541 | $-2,955,399 |
| Common Stock Payments | $-31,443 | $-11,263 | $-34,344 | $-81,992 |
| Net Investment Purchase And Sale | $-1,459,747 | $-1,201,125 | $-4,211,087 | $0 |
| Purchase Of Investment | $-1,459,747 | $-1,201,125 | $-4,211,087 | - |
| Net PPE Purchase And Sale | $-6,644 | $-159,743 | $-7,251 | $-19,269 |
| Purchase Of PPE | $-6,644 | $-159,743 | $-7,251 | $-19,269 |
| Change In Working Capital | $-341,051 | $228,023 | $661,452 | $-674,263 |
| Change In Other Current Liabilities | $-853,006 | $-1,207,329 | $-326,662 | $-897,788 |
| Change In Prepaid Assets | $308,312 | $-21,595 | $-105,132 | $686,848 |
| Change In Receivables | $203,643 | $1,456,947 | $1,093,246 | $-463,323 |
| Changes In Account Receivables | $203,643 | $1,456,947 | $1,093,246 | $-463,323 |
| Other Non Cash Items | $-37,526 | $-245,815 | $-320,077 | - |
| Stock Based Compensation | $35,079 | $47,546 | $45,084 | $71,645 |
| Depreciation Amortization Depletion | $229,075 | $181,164 | $194,321 | $188,391 |
| Depreciation And Amortization | $229,075 | $181,164 | $194,321 | $188,391 |
| Depreciation | $229,075 | $181,164 | $194,321 | $188,391 |
| Net Income From Continuing Operations | $-100,463 | $-777,619 | $1,310,180 | $1,006,684 |
| Sale Of PPE | - | - | - | $0 |
| Provisionand Write Offof Assets | - | - | - | $0 |
| Gain Loss On Sale Of PPE | - | - | - | $0 |
| Issuance Of Debt | - | - | - | - |
| Net Issuance Payments Of Debt | - | - | - | - |
| Net Long Term Debt Issuance | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
| Change In Other Current Assets | - | - | - | - |
Fetched: 2026-02-02